2016

10732 bookmarks
Custom sorting
A Possible Novel Effect for Dapagliflozin in the Management of Subcutaneous Insulin Resistance Syndrome: A Report of Two Cases - PubMed
A Possible Novel Effect for Dapagliflozin in the Management of Subcutaneous Insulin Resistance Syndrome: A Report of Two Cases - PubMed
These are the first reported cases of SIRS in which dapagliflozin, an SGLT-2 inhibitor, was used. The substantial reduction in the IM insulin dose following the addition of dapagliflozin in our reported cases of SIRS suggests a possible novel mechanism for dapagliflozin beyond its glucosuric effects …
·pubmed.ncbi.nlm.nih.gov·
A Possible Novel Effect for Dapagliflozin in the Management of Subcutaneous Insulin Resistance Syndrome: A Report of Two Cases - PubMed
Clinical studies of dapagliflozin in pediatric patients: a rapid review - PubMed
Clinical studies of dapagliflozin in pediatric patients: a rapid review - PubMed
The oral sodium-glucose cotransporter 2 inhibitor, dapagliflozin, is used to treat kidney disease, heart failure, and diabetes in adults, but has not been well studied in pediatrics, and does not have a recognized place in therapy in current practice guidelines. The purpose of this review is to summ …
·pubmed.ncbi.nlm.nih.gov·
Clinical studies of dapagliflozin in pediatric patients: a rapid review - PubMed
Dapagliflozin as an Adjunct Therapy to Insulin in Patients with Type 1 Diabetes Mellitus: Efficacy and Safety of this Combination - PubMed
Dapagliflozin as an Adjunct Therapy to Insulin in Patients with Type 1 Diabetes Mellitus: Efficacy and Safety of this Combination - PubMed
The prevalence of type 1 diabetes (T1D) is increasing worldwide. T1D reduces life expectancy due to complications including cardiovascular disease. Sodium-glucose co-transporter (SGLT) inhibitors are a new class of drugs developed to treat type 2 diabetes (T2D), and now they can be used as an adjunc …
·pubmed.ncbi.nlm.nih.gov·
Dapagliflozin as an Adjunct Therapy to Insulin in Patients with Type 1 Diabetes Mellitus: Efficacy and Safety of this Combination - PubMed
Efficacy and safety of the SGLT2 inhibitor dapagliflozin in type 1 diabetes: A meta-analysis of randomized controlled trials - PubMed
Efficacy and safety of the SGLT2 inhibitor dapagliflozin in type 1 diabetes: A meta-analysis of randomized controlled trials - PubMed
Sodium glucose cotransporter-2 (SGLT2) is a sodium-dependent glucose transporter responsible for renal absorption of glucose. Dapagliflozin is an SGLT2 inhibitor used in patients with type 1 diabetes to promote urinary glucose excretion, but to date, randomized controlled trials (RCTs) to evaluate t …
·pubmed.ncbi.nlm.nih.gov·
Efficacy and safety of the SGLT2 inhibitor dapagliflozin in type 1 diabetes: A meta-analysis of randomized controlled trials - PubMed
Efficacy of Low-dose Dapagliflozin in Young People with Type 1 Diabetes - PubMed
Efficacy of Low-dose Dapagliflozin in Young People with Type 1 Diabetes - PubMed
Objective Young people with type 1 diabetes are likely to gain body weight and not achieve optimal glycemic control with only high doses of insulin. This study examined the efficacy of the sodium-glucose cotransporter 2 (SGLT2) inhibitor dapagliflozin as an adjunct-to-insulin therapy in young Japane …
·pubmed.ncbi.nlm.nih.gov·
Efficacy of Low-dose Dapagliflozin in Young People with Type 1 Diabetes - PubMed
Insulin dose reduction in dapagliflozin combination therapy for type 1 diabetes mellitus: the RISING-STAR study - PubMed
Insulin dose reduction in dapagliflozin combination therapy for type 1 diabetes mellitus: the RISING-STAR study - PubMed
To clarify the frequency of hypoglycemia in patients with type 1 diabetes mellitus receiving dapagliflozin combination therapy to reduce their basal insulin dose. Sixty subjects were assigned to two groups according to their basal insulin-to-total daily dose (TDD) ratio: group A (basal insulin/TDD & …
·pubmed.ncbi.nlm.nih.gov·
Insulin dose reduction in dapagliflozin combination therapy for type 1 diabetes mellitus: the RISING-STAR study - PubMed
Long-term (52-week) efficacy and safety of dapagliflozin as an adjunct to insulin therapy in Japanese patients with type 1 diabetes: Subgroup analysis of the DEPICT-2 study - PubMed
Long-term (52-week) efficacy and safety of dapagliflozin as an adjunct to insulin therapy in Japanese patients with type 1 diabetes: Subgroup analysis of the DEPICT-2 study - PubMed
Efficacy and safety results from the Japanese subpopulation of the DEPICT-2 study were generally consistent with those from the overall population, indicating that long-term dapagliflozin adjunct to insulin therapy improves glycaemic control without an increased risk of hypoglycaemia but with a risk …
·pubmed.ncbi.nlm.nih.gov·
Long-term (52-week) efficacy and safety of dapagliflozin as an adjunct to insulin therapy in Japanese patients with type 1 diabetes: Subgroup analysis of the DEPICT-2 study - PubMed
Long-term efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes: pooled 52-week outcomes from the DEPICT-1 and -2 studies - PubMed
Long-term efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes: pooled 52-week outcomes from the DEPICT-1 and -2 studies - PubMed
Over 52 weeks, dapagliflozin provided glycaemic and weight benefits, with no increased frequency of severe hypoglycaemia compared with placebo. More DKA events were reported with dapagliflozin than placebo, highlighting the importance of appropriate patient selection, education and risk-mitigation s …
·pubmed.ncbi.nlm.nih.gov·
Long-term efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes: pooled 52-week outcomes from the DEPICT-1 and -2 studies - PubMed
Reduced O-GlcNAcylation and tubular hypoxia contribute to the antifibrotic effect of SGLT2 inhibitor dapagliflozin in the diabetic kidney - PubMed
Reduced O-GlcNAcylation and tubular hypoxia contribute to the antifibrotic effect of SGLT2 inhibitor dapagliflozin in the diabetic kidney - PubMed
Diabetic kidney disease is a worldwide epidemic, and therapies are incomplete. Clinical data suggest that improved renal outcomes by Na+-glucose cotransporter 2 inhibitor (SGLT2i) are partly beyond their antihyperglycemic effects; however, the mechanisms are still elusive. Here, we invest …
·pubmed.ncbi.nlm.nih.gov·
Reduced O-GlcNAcylation and tubular hypoxia contribute to the antifibrotic effect of SGLT2 inhibitor dapagliflozin in the diabetic kidney - PubMed
Therapeutic effect and rebound evaluation of dapagliflozin on glycated hemoglobin (HbA1c) in type 1 diabetes mellitus patients - PubMed
Therapeutic effect and rebound evaluation of dapagliflozin on glycated hemoglobin (HbA1c) in type 1 diabetes mellitus patients - PubMed
Dapagliflozin has been used to treat patients with type 1 diabetes mellitus; however, the actual drug efficacy of dapagliflozin on glycated hemoglobin (HbA1c) and whether there is a rebound from dapagliflozin efficacy on HbA1c remain unknown. The present study aimed to explore the actual therapeutic …
·pubmed.ncbi.nlm.nih.gov·
Therapeutic effect and rebound evaluation of dapagliflozin on glycated hemoglobin (HbA1c) in type 1 diabetes mellitus patients - PubMed
Interventions To Attenuate Vascular Calcification Progression in Chronic Kidney Disease: A Systematic Review of Clinical Trials - PubMed
Interventions To Attenuate Vascular Calcification Progression in Chronic Kidney Disease: A Systematic Review of Clinical Trials - PubMed
Currently, there are insufficient or conflicting data regarding interventions evaluated in clinical trials for mitigation of vascular calcification in people with CKD. Therapy involving magnesium or sodium thiosulfate appears most promising, but evaluable studies were small and of short duration.
·pubmed.ncbi.nlm.nih.gov·
Interventions To Attenuate Vascular Calcification Progression in Chronic Kidney Disease: A Systematic Review of Clinical Trials - PubMed
Oral activated charcoal adsorbent (AST-120) ameliorates chronic kidney disease-induced intestinal epithelial barrier disruption - PubMed
Oral activated charcoal adsorbent (AST-120) ameliorates chronic kidney disease-induced intestinal epithelial barrier disruption - PubMed
CKD animals exhibited depletion of the key protein constituents of the colonic epithelial TJ which was associated with systemic inflammation, oxidative stress and endotoxemia. Administration of AST-120 attenuated uremia-induced disruption of colonic epithelial TJ and the associated endotoxemia, oxid …
·pubmed.ncbi.nlm.nih.gov·
Oral activated charcoal adsorbent (AST-120) ameliorates chronic kidney disease-induced intestinal epithelial barrier disruption - PubMed
An Investigation into the Effects of Omega-3 on Uremic Pruritus in Hemodialysis Patients: A Randomized Crossover Clinical Trial - PubMed
An Investigation into the Effects of Omega-3 on Uremic Pruritus in Hemodialysis Patients: A Randomized Crossover Clinical Trial - PubMed
Itching along with other problems can be one of the factors exacerbating the sufferings and disturbing the comfort of patients with chronic renal failure. The present research aimed to study the effects of omega-3 on the treatment of uremic pruritus in hemodialysis (HD) patients. In this crossover r …
·pubmed.ncbi.nlm.nih.gov·
An Investigation into the Effects of Omega-3 on Uremic Pruritus in Hemodialysis Patients: A Randomized Crossover Clinical Trial - PubMed
Fucoidan from Laminaria japonica protects renal tubular epithelial cells from uric acid induced NLRP3-mediated pyroptosis through inhibition of NF-κB pathway - ScienceDirect
Fucoidan from Laminaria japonica protects renal tubular epithelial cells from uric acid induced NLRP3-mediated pyroptosis through inhibition of NF-κB pathway - ScienceDirect
Hyperuricemia is a common metabolic disease with prominent morbidity, it can lead to many adverse effects and complications, such as chronic nephrosis…
·sciencedirect.com·
Fucoidan from Laminaria japonica protects renal tubular epithelial cells from uric acid induced NLRP3-mediated pyroptosis through inhibition of NF-κB pathway - ScienceDirect
Targeting Uremic Toxins to Prevent Peripheral Vascular Complications in Chronic Kidney Disease - PMC
Targeting Uremic Toxins to Prevent Peripheral Vascular Complications in Chronic Kidney Disease - PMC
Chronic kidney disease (CKD) exhibits progressive kidney dysfunction and leads to disturbed homeostasis, including accumulation of uremic toxins, activated renin-angiotensin system, and increased oxidative stress and proinflammatory cytokines. Patients ...
·ncbi.nlm.nih.gov·
Targeting Uremic Toxins to Prevent Peripheral Vascular Complications in Chronic Kidney Disease - PMC
Kimera Labs
Kimera Labs
Leading exosome biotechnology laboratory. Specializes in the production of perinatal MSC-derived exosome products for cosmetic treatment. Request a lab tour.
·kimeralabs.com·
Kimera Labs
How Strength Training Boosts the Brain - YouTube
How Strength Training Boosts the Brain - YouTube
How Strength Training Boosts the Brain Get my Free Guide: 11 Science-Backed Steps to Help Boost Memory and Prevent Dementia https://www.austinperlmutter.com/memoryguide Full blog: https://www.austinperlmutter.com/post/how-weightlifting-boosts-your-brain Regular exercise lowers the risk of brain issues like depression and Alzheimer’s disease. Resistance training should also be considered for its brain health benefits. Benefits of Strength Training for Brain Health: 1. Better brain health in those who engage in resistance training. 2. Improved brain function, particularly in the elderly, from starting weightlifting. 3. Cognitive improvements in people with cognitive decline after resistance training. 4. Decreased depressive symptoms observed through resistance training. 5. Regulation of Metabolic Balance and Immunity seem to be key Tips for Effective Resistance Training: Start light and gradually increase weight. Consider working with a trainer for guidance. Group classes can boost motivation and provide social benefits. Resistance bands offer a versatile and effective alternative. Pay attention to your body to avoid injuries. Include leg exercises for maximum benefit. Ensure adequate protein intake and consider creatine supplementation for muscle and brain health. Check out my newsletter! https://www.austinperlmutter.com/newsletter This content is not intended to diagnose, treat, cure, or prevent disease. The information provided by this video should not be used as individual medical advice. You should always consult your healthcare provider for individual recommendations and treatment. #exercise #weightlifting #neuroscience
·youtube.com·
How Strength Training Boosts the Brain - YouTube
Breastfeeding vs. Formula Feeding: What's Best for Your Baby? - YouTube
Breastfeeding vs. Formula Feeding: What's Best for Your Baby? - YouTube
Join us as we explore the age-old debate surrounding infant nutrition. In this video, we weigh the pros and cons of breastfeeding and formula feeding, providing evidence-based insights to help you make an informed decision for your baby's health. From nutritional benefits to practical considerations, we cover everything you need to know about these two feeding methods. Whether you're a new parent or simply curious about the science behind infant nutrition, this video is for you. #breastfeeding #baby #wellness Supercharge Your Health with Clinically Proven Nitric Oxide Solutions – Visit Now https://n1o1.com 🔔 Boost Your Health with Nitric Oxide: Unlock Its Secrets for Peak Performance & Wellbeing. Subscribe Now! https://www.youtube.com/@DrNathanSBryanNitricOxide/?sub_confirmation=1 ✅Important Links to Follow 🔗Linktree https://linktr.ee/n1o1 ✅ Stay Connected With Us. 👉Facebook: https://www.facebook.com/pneumanitricoxide/ 👉Instagram: https://www.instagram.com/n1o1.by.pneuma.nitric.oxide/ 👉Website: https://drnathansbryan.com/ ============================= ✅ Recommended Playlists 👉 Redefining Medicine - Dr. Nathan Bryan https://www.youtube.com/watch?v=iK9JzHpNdHM&list=PLZm8V0VIi2Y43P1qewE4uZv8mkpW_xm_Y&pp=iAQB 👉 Shorts https://www.youtube.com/watch?v=ztMZuUVyuHk&list=PLZm8V0VIi2Y6JJMHY7CeVvlOGVVAiQqhf&pp=iAQB ✅ Other Videos You Might Be Interested In Watching: 👉 Unlocking the Power of Nitric Oxide: Transforming Modern Medicine & Patient Care https://www.youtube.com/watch?v=tmj9FZqIV2g 👉 Disclosures and transparency on companies and products in which I am and am not involved. https://www.youtube.com/watch?v=o5kr_IeWnVk&t=18s 👉 Regenacast Podcast interview with Sean Berman of Cell Surgical Network. https://www.youtube.com/watch?v=9cwx4nIM9Mw&t=29s 👉 Sugar Crush Podcast with Dr. Rick Jacoby and Dr. Nathan S Bryan https://www.youtube.com/watch?v=cwo71eKe_Ic 👉 There is only one way to deliver nitric oxide to the human body. https://www.youtube.com/watch?v=nN2275k89ic ============================= ✅ About Dr Nathan Bryan Nitric Oxide. Nathan S. Bryan, Ph.D CEO/FOUNDER OF NO2U & NITRIC OXIDE LEADING EXPERT Dr. Bryan has made many seminal discoveries in the Nitric Oxide field, resulting in over a dozen U.S. and International patents. He is also a successful entrepreneur who has brought his Nitric Oxide technology to consumers. Dr. Bryan has published many highly cited papers and authored or edited five books. His work has made him a recognized international leader in molecular medicine and Nitric Oxide biochemistry. If your body can't make Nitric Oxide, we are here to help! 🔔 Nitric oxide: Your secret weapon for health, performance & longevity. Subscribe & unlock the knowledge! https://www.youtube.com/@DrNathanSBryanNitricOxide/?sub_confirmation=1 ================================= ⚠️DISCLAIMER: We do not accept any liability for any loss or damage incurred from you acting or not acting as a result of watching any of our publications. You acknowledge that you use the information we provide at your own risk. Do your research. Copyright Notice: This video and our YouTube channel contain dialogue, music, and images that are the property of Dr Nathan Bryan Nitric Oxide. You are authorized to share the video link and channel and embed this video in your website or others as long as a link back to our YouTube channel is provided. © Dr Nathan Bryan Nitric Oxide
·youtube.com·
Breastfeeding vs. Formula Feeding: What's Best for Your Baby? - YouTube
Are the 10 Horns of the Beast the 10 Lost Tribes of Israel - A Jaw Dropping Discovery - YouTube
Are the 10 Horns of the Beast the 10 Lost Tribes of Israel - A Jaw Dropping Discovery - YouTube
Are the 10 Horns on the Beast, the 10 Lost Tribes of Israel? How could anyone say this? Well there are 10 horns on the beast and 10 tribes from Israel's northern kingdom. And there are 2 horns on the second beast or false prophet and 2 tribes from Israel's southern kingdom. Coincidence? If this theory is true, see how it revolutionizes many Bible prophecies such as the toes of iron and clay mixed, and the theory the Antichrist is from the tribe of Dan. Click here to watch this jaw-dropping theory and discover what the implications are of a Beast Empire made up of both Gentiles and Israelites This video contains AI images from our AI Artist team including Christian Vichi, Robert Forsbach, Jonathan Merrill, Jason Lawrence, Nelson, and FreethroughChrist
·youtube.com·
Are the 10 Horns of the Beast the 10 Lost Tribes of Israel - A Jaw Dropping Discovery - YouTube